Compare WERN & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WERN | ENOV |
|---|---|---|
| Founded | 1956 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Fluid Controls |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 1994 | 2008 |
| Metric | WERN | ENOV |
|---|---|---|
| Price | $28.59 | $21.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 8 |
| Target Price | $31.21 | ★ $48.75 |
| AVG Volume (30 Days) | ★ 944.3K | 895.1K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.94% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,974,396,000.00 | N/A |
| Revenue This Year | $21.44 | $6.36 |
| Revenue Next Year | $6.87 | $5.31 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $23.02 | $21.00 |
| 52 Week High | $38.45 | $38.56 |
| Indicator | WERN | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 39.55 | 42.44 |
| Support Level | $26.64 | $21.33 |
| Resistance Level | $29.62 | $23.57 |
| Average True Range (ATR) | 1.04 | 1.15 |
| MACD | 0.13 | -0.13 |
| Stochastic Oscillator | 34.90 | 14.61 |
Werner Enterprises Inc is a transportation and logistics company engaged in transporting truckload shipments of general commodities in both interstate and intrastate commerce. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.